首页|泮托拉唑联合奥曲肽对消化性溃疡出血患者的疗效及对炎症因子水平的影响

泮托拉唑联合奥曲肽对消化性溃疡出血患者的疗效及对炎症因子水平的影响

扫码查看
目的 探讨泮托拉唑联合奥曲肽对消化性溃疡出血的疗效及对炎症因子[白介素-6(IL-6)、白介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)]水平的影响。方法 选取2021年2月—2022年5月信阳职业技术学院附属医院收治的消化性溃疡出血110例,依据治疗方式分组,给予单一泮托拉唑静脉滴注治疗的55例作为对照组,在对照组基础上联合奥曲肽治疗的55例作为联合组。比较两组患者治疗总有效率、平均住院时间、出血量、止血时间等临床相关指标及炎症因子(IL-6、IL-8、TNF-α)水平以及胃液PH值。结果 联合组总有效率96。36%,高于对照组(78。18%)(P<0。05);联合组平均输血量(314。45±14。44)mL,少于对照组的(426。93±14。40)mL,平均止血时间及住院时间分别为(21。59±1。28)h及(4。79±0。16)d,均短于对照组的(38。22±1。21)h及(6。59±0。17)d(P<0。05);两组治疗前炎症因子IL-6、IL-8、TNF-α水平比较无统计学意义(P>0。05),联合组治疗后IL-6、1L-8、TNF-α 水平分别为(133。48±20。26)μg/mL(95。51±7。85)pg/mL 和(1。01±0。16)ng/mL,均低于对照组(P<0。05);两组治疗前胃液pH值比较无统计学意义(P>0。05),联合组治疗后胃液pH值(6。11±2。29),高于对照组的(5。78±2。21)(P<0。05)。结论 消化性溃疡患者联合泮托拉唑和奥曲肽疗效显著,能够提高治疗效率并减低出血量,缩短止血时间和住院时间,有效改善消化道炎症因子水平,值得临床推广。
Effect of pantoprazole combined with octreotide on the level of inflammatory factors in patients with peptic ulcer bleeding
Objective To investigate the efficacy of pantoprazole combined with octreotide in treating peptic ulcer bleed-ing and the effects on the levels of inflammatory factors[interleukin-6(IL-6),interleukin-8(IL-8),tumor nec-rosis factor-α(TNF-α)].Methods A total of 110 cases of peptic ulcer hemorrhage admitted to the Affiliated Hos-pital of Xinyang Vocational and Technical College from February 2021 to May 2022 were selected and divided into groups according to the treatment methods.55 cases were treated with single Pantoprazole intravenous infusion as the control group,and 55 cases were treated with octreotide on the basis of the control group as the combination group.The total ef-fective rate,average hospital stay,blood loss,hemostatic time and other clinical indicators,levels of inflammatory fac-tors(IL-6,IL-8,TNF-α)and PH value of gastric juice were compared between the two groups.Results The total effective rate of the combined group was 96.36%,higher than that of the control group(78.18%)(P<0.05).The average blood transfusion volume of the combined group was(314.45±14.44)mL,which was lower than that of the control group(426.93±14.40)mL.The average hemostatic time and hospitalization time were(21.59±1.28)h and(4.79±0.16)d,respectively.It was shorter than that of control group(38.22±1.21)h and(6.59±0.17)d(P<0.05).There was no statistical significance in the levels of inflammatory factors IL-6,IL-8 and TNF-α be-tween the two groups before treatment(P>0.05).After treatment,the levels of IL-6,IL-8 and TNF-α in combi-nation group were(133.48±20.26)pg/mL(95.51±7.85)pg/mL and(1.01±0.16)ng/mL,respectively,which were lower than those in control group(P<0.05).There was no significant difference in the pH value of gastric juice between the two groups before treatment(P>0.05).The pH value of gastric juice after treatment in the combined group(6.11±2.29)was higher than that in the control group(5.78±2.21)(P<0.05).Conclusion The combina-tion of pantoprazole and octreotide is effective in patients with peptic ulcer,which can improve treatment efficiency,re-duce blood loss,shorten hemostasis time and hospital stay,and effectively improve the level of gastrointestinal inflamma-tory factors,which is worthy of clinical promotion.

Peptic ulcer hemorrhageOctreotidePantoprazoleCurative effectInflammatory factor

杨琳娜

展开 >

信阳职业技术学院附属医院消化内科,河南信阳 464000

消化性溃疡出血 奥曲肽 泮托拉唑 疗效 炎症因子

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(12)